{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:52:53Z","timestamp":1771037573157,"version":"3.50.1"},"reference-count":47,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Symmetry"],"abstract":"<jats:p>Oxindole derivatives are a large group of compounds that can play the role of Adenosine triphosphate (ATP) competitive inhibitors. The possibility of modification of such compounds by addition of active groups to both cyclic systems of oxindole allows the obtaining of derivatives showing significant affinity toward cyclin-dependent kinase (CDK) proteins. Overexpression of that enzyme is observed in the case of most cancers. The discovery of new efficient inhibitors, which could be used in the development of targeted therapies, is one of the current goals setting trends in recent research. In this research, an oxindole molecular core was used, which was modified by the addition of different substituents to both side chains. The realized procedure allowed the creation of a set of oxindole derivatives characterized by binding affinity values and molecular descriptors evaluated during docking procedures and QSAR calculations. The most promising structures characterized by best sets of parameters were used during the molecular dynamics stage. The analysis of structural and energetic properties of systems obtained during this stage of computation gives an indication of inhibitors creating the most stable complexes, characterized by the highest affinity. During this stage, two structures were selected, where affinity towards potential nanocarriers was evaluated. Realized calculations confirmed a significant role of stacking interactions in the stabilization of ligand complexes with fullerene molecules. Obtained data indicates that complexes of oxindole derivatives and considered nanocarriers exhibit significant potential in the creation of immobilized drugs, and can be used in the development of targeted therapies.<\/jats:p>","DOI":"10.3390\/sym11080974","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T11:39:37Z","timestamp":1564659577000},"page":"974","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Investigation of the Inhibition Potential of New Oxindole Derivatives and Assessment of Their Usefulness for Targeted Therapy"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7268-4956","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Czele\u0144","sequence":"first","affiliation":[{"name":"Department of Physical Chemistry, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Kurpinskiego 5, 85-096 Bydgoszcz, Poland"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","article-title":"Roberts JM CDK Inhibitors: Cell Cycle Regulators and Beyond","volume":"14","author":"Besson","year":"2008","journal-title":"Dev. Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Barbacid M Cell cycle, CDKs and cancer: A changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.cellbio.13.1.261","article-title":"CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors","volume":"13","author":"Morgan","year":"1997","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/35106065","article-title":"To cycle or not to cycle: A critical decision in cancer","volume":"1","author":"Malumbres","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbamcr.2010.04.004","article-title":"A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding","volume":"1803","author":"Child","year":"2010","journal-title":"Biochim. Biophys. Acta. Mol. Cell Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/cb500135f","article-title":"An Inhibitor\u2019s-Eye View of the ATP-Binding Site of CDKs in Different Regulatory States","volume":"9","author":"Echalier","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4161\/cbt.19589","article-title":"Cyclin dependent kinases in cancer","volume":"13","author":"Canavese","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3892\/or.2013.2334","article-title":"Indirubin-3\u2032-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells","volume":"29","author":"LEE","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/9035","article-title":"Indirubin the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases","volume":"1","author":"Hoessel","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shin, E.K., and Kim, J.K. (2012). Indirubin derivative E804 inhibits angiogenesis. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-164"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/bjoc.2000.1546","article-title":"Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells","volume":"84","author":"Marko","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/jnr.22723","article-title":"The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons","volume":"89","author":"Martin","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/jbc.M002466200","article-title":"Indirubins Inhibit Glycogen Synthase Kinase-3beta and CDK5\/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer\u2019s Disease. A PROPERTY COMMON TO MOST CYCLIN-DEPENDENT KINASE INHIBITORS?","volume":"276","author":"Leclerc","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1016\/j.bmc.2006.05.036","article-title":"Synthesis of novel 5-substituted indirubins as protein kinases inhibitors","volume":"14","author":"Beauchard","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0968-0896(03)00036-1","article-title":"Synthesis of potent oxindole CDK2 inhibitors","volume":"11","author":"Dermatakis","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bmcl.2003.12.009","article-title":"A new series of potent oxindole inhibitors of CDK2","volume":"14","author":"Luk","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"(2016). Czele\u0144 Molecular dynamics study on inhibition mechanism of CDK-2 and GSK-3\u03b2 by CHEMBL272026 molecule. Struct. Chem., 27, 1807\u20131818.","DOI":"10.1007\/s11224-016-0803-0"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00894-017-3395-8","article-title":"Inhibition mechanism of CDK-2 and GSK-3\u03b2 by a sulfamoylphenyl derivative of indoline\u2014A molecular dynamics study","volume":"23","year":"2017","journal-title":"J. Mol. Model."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/sym11081048","article-title":"The Immobilization of Oxindole Derivatives with Use of Cube Rhombellane Homeomorphs","volume":"11","author":"Szefler","year":"2019","journal-title":"Symmetry"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Szefler, B., and Czele\u0144, P. (2019). Docking of Cisplatin on Fullerene Derivatives and Some Cube Rhombellane Functionalized Homeomorphs. Symmetry, 11.","DOI":"10.3390\/sym11070874"},{"key":"ref_21","first-page":"7","article-title":"Docking of indolizine derivatives on cube rhombellane functionalized homeomorphs","volume":"63","author":"Szefler","year":"2018","journal-title":"Stud. Univ. Babes-Bolyai Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11095-011-0558-7","article-title":"Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug","volume":"29","author":"Morgen","year":"2012","journal-title":"Pharm. Res."},{"key":"ref_23","first-page":"133","article-title":"Drug delivery and nanoparticles:applications and hazards","volume":"3","author":"Borm","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2012.05.051","article-title":"Nanotechnology applied to overcome tumor drug resistance","volume":"162","author":"Gao","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10856-011-4237-3","article-title":"Low-temperature 1H-NMR spectroscopic study of doxorubicin influence on the hydrated properties of nanosilica modified by DNA","volume":"22","author":"Turov","year":"2011","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.2147\/IJN.S172907","article-title":"Nanotechnology, from quantum mechanical calculations up to drug delivery","volume":"13","author":"Szefler","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Cataldo, F., and Da Ros, T. (2008). Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes, Springer.","DOI":"10.1007\/978-1-4020-6845-4"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1166\/jbn.2015.2058","article-title":"Application of C60 Fullerene-Doxorubicin Complex for Tumor Cell Treatment In Vitro and In Vivo","volume":"11","author":"Panchuk","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/15363830500237267","article-title":"Is the C60 Fullerene Molecule Toxic?","volume":"13","author":"Andrievsky","year":"2005","journal-title":"Fuller. Nanotub. Carbon Nanostruct."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1166\/jbn.2012.1404","article-title":"Water-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane","volume":"8","author":"Prylutska","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1021\/nl062515f","article-title":"Translocation of C60 and Its Derivatives Across a Lipid Bilayer","volume":"7","author":"Qiao","year":"2007","journal-title":"Nano Lett."},{"key":"ref_32","unstructured":"TURBOMOLE 7.0. Available online: http:\/\/www.turbomole.com\/."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.drudis.2008.07.006","article-title":"Principles for 3D\/4D QSAR classification of drugs","volume":"13","author":"Potemkin","year":"2008","journal-title":"Drug. Discov. Today"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10822-008-9203-x","article-title":"A new paradigm for pattern recognition of drugs","volume":"22","author":"Potemkin","year":"2008","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_35","unstructured":"Chemosophia (2017, March 01). Available online: http:\/\/www.chemosophia.com\/."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/aic.690480220","article-title":"Fast solvent screening via quantum chemistry: COSMO-RS approach","volume":"48","author":"Eckert","year":"2002","journal-title":"AIChE J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_38","unstructured":"PubChem (2019, May 01). Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1023\/A:1023611131068","article-title":"A Method for Multiconformational Modeling of the Three-Dimensional Shape of a Molecule","volume":"43","author":"Bartashevich","year":"2002","journal-title":"J. Struct. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1039\/C4MB00491D","article-title":"Permethrin and its metabolites affect Cu\/Zn superoxide conformation: Fluorescence and in silico evidences","volume":"11","author":"Rosita","year":"2015","journal-title":"Mol. Biosyst."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00044-016-1761-1","article-title":"Inhibitors of multidrug efflux pumps of Pseudomonas aeruginosa from natural sources: An in silico high-throughput virtual screening and in vitro validation","volume":"26","author":"Mangiaterra","year":"2017","journal-title":"Med. Chem. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model","volume":"97","author":"Bayly","year":"1993","journal-title":"J. Phys. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1063\/1.432526","article-title":"Generalized Langevin equation approach for atom\/solid-surface scattering: General formulation for classical scattering off harmonic solids","volume":"64","author":"Adelman","year":"1976","journal-title":"J. Chem. Phys."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: An Efficient Program for End-State Free Energy Calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"ref_47","unstructured":"Case, D.A., Babin, V., Berryman, J.T., Betz, R.M., Cai, Q., Cerutti, D.S., Cheatham, T.E., Darden, T.A., Duke, R.E., and Gohlke, H. (2014). AMBER 14, University of California."}],"container-title":["Symmetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-8994\/11\/8\/974\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:12:23Z","timestamp":1760188343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-8994\/11\/8\/974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["sym11080974"],"URL":"https:\/\/doi.org\/10.3390\/sym11080974","relation":{},"ISSN":["2073-8994"],"issn-type":[{"value":"2073-8994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}